BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11888078)

  • 1. Carisoprodol: an unrecognized drug of abuse.
    Bailey DN; Briggs JR
    Am J Clin Pathol; 2002 Mar; 117(3):396-400. PubMed ID: 11888078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of drug testing as an early warning programme: the experience of the Republic of Korea.
    Chung H
    Bull Narc; 2005; 57(1-2):231-48. PubMed ID: 21338024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution.
    McIntyre IM; Sherrard J; Lucas J
    J Anal Toxicol; 2012 Apr; 36(3):177-81. PubMed ID: 22417833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine.
    Wang G; Huynh K; Barhate R; Rodrigues W; Moore C; Coulter C; Vincent M; Soares J
    J Anal Toxicol; 2011 Mar; 35(2):108-12. PubMed ID: 21396230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of carisoprodol and acetaminophen in an attempted suicide by liquid chromatography-mass spectrometry with positive electrospray ionization.
    Matsumoto T; Sano T; Matsuoka T; Aoki M; Maeno Y; Nagao M
    J Anal Toxicol; 2003 Mar; 27(2):118-22. PubMed ID: 12670008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carisoprodol (soma): abuse potential and physician unawareness.
    Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
    J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug.
    Høiseth G; Karinen R; Sørlid HK; Bramness JG
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):345-9. PubMed ID: 19663822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of carisoprodol and meprobamate in human hair using solid-phase extraction and gas chromatography/mass spectrometry of the trimethylsilyl derivatives.
    Kim JY; In MK; Paeng KJ; Chung BC
    Rapid Commun Mass Spectrom; 2005; 19(21):3056-62. PubMed ID: 16200657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patients.
    Tse SA; Atayee RS; Best BM; Pesce AJ
    J Anal Toxicol; 2012 May; 36(4):221-31. PubMed ID: 22511696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH; Johnson-Davis KL
    Methods Mol Biol; 2016; 1383():105-14. PubMed ID: 26660179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose carisoprodol during pregnancy and lactation.
    Briggs GG; Ambrose PJ; Nageotte MP; Padilla G
    Ann Pharmacother; 2008 Jun; 42(6):898-901. PubMed ID: 18460586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.
    Høiseth G; Bramness JG; Christophersen AS; Mørland J
    Int J Legal Med; 2007 Sep; 121(5):403-9. PubMed ID: 17115170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting carisoprodol metabolism in pain patients using urinary excretion data.
    Tse SA; Atayee RS; Ma JD; Best BM
    J Anal Toxicol; 2014 Apr; 38(3):122-8. PubMed ID: 24488112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carisoprodol withdrawal syndrome.
    Reeves RR; Beddingfield JJ; Mack JE
    Pharmacotherapy; 2004 Dec; 24(12):1804-6. PubMed ID: 15585447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carisoprodol concentrations from different anatomical sites: three overdose cases.
    Backer RC; Zumwalt R; McFeeley P; Veasey S; Wohlenberg N
    J Anal Toxicol; 1990; 14(5):332-4. PubMed ID: 2263072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative determination of meprobamate and carisoprodol by gas chromatography in different cases of poisoning].
    Maes R; Bouche R; Laruelle L
    Eur J Toxicol; 1970; 3(2):140-3. PubMed ID: 5520468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.